Articles On Holista CollTech (ASX:HCT)
Title | Source | Codes | Date |
---|---|---|---|
Closing Bell: Uranium stocks jump on Russia news; Resolute pays $160m to settle Mali dispute
ASX up as mining gains offset tech and bank losses Silex, Paladin and uranium stocks soar on supply squeeze Goldman cuts Aussie GDP forecast as US tariffs loom After a soft start to the day, the ASX bounced back and closed the day 0.3% ... |
Stockhead | HCT | 4 days ago |
Closing Bell: ASX up as traders dump MinRes; Ordell jumps on standout gold drill results
ASX closes higher despite Mineral Resources dip US dollar weakens amid uncertain election polling Ordell, Blue Star Helium star for small caps The ASX closed Monday higher by 0.5%, riding the wave of optimism from Wall Street. Howev... |
Stockhead | HCT | 2 weeks ago |
ASX August Winners: The 50 best stocks in a volatile month for markets
S&P/ASX 200 recovers from heavy volatility early in the month to finish up 0.47% in August S&P Dow Jones Indices said mid-caps led the gains putting them ahead of large and small caps YTD Larvotto Resources rose on the back of Chin... |
Stockhead | HCT | 2 months ago |
Closing Bell: CPI reading shifts rate cut outlook; Tabcorp plunges 15pc while Felix Gold soars
Aussie stocks dropped despite Wall Street edging up ahead of Nvidia’s report Inflation eased to 3.5pc, impacting rate cut predictions Fortescue and Flight Centre reported gains; Woolworths and Tabcorp faced losses Aussie stocks dropped... |
Stockhead | HCT | 2 months ago |
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators
ASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price rebound, energy stocks fell The ASX 200 ended its 10-day winning streak, dipping by 0.04% after a weak session on Wall Street overnight.... |
Stockhead | HCT | 2 months ago |
Closing Bell: Tech, Miners fuel ASX winning run; but Yancoal sinks 14pc after dividend halt
ASX 200 nears 8,000 points, boosted by mining stocks Monadelphous and Baby Bunting rose; Yancoal and Dexus fell RBA considered lifting rates in August, minutes revealed The S&P/ASX 200 index rose by 0.2% to finish near 8,000 points... |
Stockhead | HCT | 3 months ago |
Closing Bell: Gold, utilities soar as A2 Milk sags; ASX 200 keeps winning streak alive
ASX flattish on Monday, with utilities and gold stocks leading A2 Milk’s shares plummeted 20pc amid challenges in China Westpac and Suncorp saw gains of nearly 2pc after results release Trading on the ASX was relatively quiet on Monday... |
Stockhead | HCT | 3 months ago |
Top 10 at 11: Lithium takeover and antimony acrimony are making today’s news
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | HCT | 3 months ago |
Closing Bell: ASX struck down again as $100bn wiped out; tech stocks take biggest hit
The ASX 200 dropped over 3% on Monday amid recession fears and weak US data Over $100 billion was wiped off the Aussie market in two days Global markets fell sharply, while safe-haven assets like gold and the yen gained The ASX 200 inde... |
Stockhead | HCT | 3 months ago |
Closing Bell: Spacetalk launched… but it’s red alert for the rest of the ASX
ASX smacked after Wall Street sell-off sparked a red day around the world. ALL sectors lower on Friday. Yep… all 11 of them. Small caps led by Spacetalk and Alto Metals The local benchmark index is wallowing back under 8,000 points,... |
Stockhead | HCT | 3 months ago |
Closing Bell: ASX axed in regional rout while mini-biotech Tissue Repair soars on TGA nod
ASX and regional markets are sharply lower after Wall St tech crunch All 11 local sectors hit, InfoTech smashed hardest on -2.7pc Tissue Repair leads small caps on happy TGA approval news The benchmark has followed sharp falls across... |
Stockhead | HCT | 3 months ago |
Top 10 at 11: Garnets – that’s what’s winning the morning. (Didn’t see that coming, did you?)
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the... |
Stockhead | HCT | 3 months ago |
Closing Bell: Local markets and key commodities slump together on Monday
ASX 200 ends 0.5pc lower after a difficult start to the week Energy Sector the worst of some poor to middling performances Small caps led by AuMake on news of a new deal in China Last week’s record highs seem a distant memory for the... |
Stockhead | HCT | 4 months ago |
Closing Bell: Markets are in revolution and the ASX just stormed its psychological Bastille
ASX 200 punches through 8,000 on Monday All sectors higher Small cap miners led by Aldoro Resources Local markets surged into record territory on Monday, pushing through the 8,000 threshold as traders played catch up to Wall Street’s r... |
Stockhead | HCT | 4 months ago |
ASX June Winners: The best 50 stocks as inflation spikes
S&P/ASX 200 rose 1% in June with large caps leading gains with mid, small and emerging companies lagging S&P/ASX 200 financials and consumer staples were the top performers in June with materials the biggest laggard Urea fertiliser... |
Stockhead | HCT | 4 months ago |
Closing Bell: Tech, Energy weigh down ASX; Schrole up almost 200pc on acquisition deal
Aussie stocks start the week flat; energy and tech sectors lead declines Investor caution prevails ahead of RBA rates decision Chinese Premier Li Qiang meets PM in Canberra today Aussie stocks had a lacklustre start to the week on Monda... |
Stockhead | HCT | 5 months ago |
Closing Bell: Most ASX sectors flashing red today, as RAU makes solid market debut
ASX200 dropped on Friday, extending its weekly loss despite Wall Street’s highs Telix Pharma halted US IPO; Tabcorp jumps 10pc on NSW tax reform Germany works to soften EU tariffs on Chinese electric cars The ASX200 dropped by -0.3% on... |
Stockhead | HCT | 5 months ago |
Closing Bell: ASX gains as jobless rate eases; MRQ almost triples on lithium JV deal
ASX rises +0.5pc driven by tech, banking, and property sectors This comes as US Fed maintains rates, now plans only one cut in 2024 Aussie unemployment drops to 4pc in May, but analysts predict further rises Aussie shares rose by +0.5%... |
Stockhead | HCT | 5 months ago |
Top 10 at 10: Which tiny explorer caught the eye of one of Australia’s biggest gold companies?
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | HCT | 5 months ago |
Closing Bell: ASX dips, goldies lead, and Forrestania jumps 140pc on iron ore play
ASX 200 dips amid Wall Street closure for Memorial Day Commodities bounce back; gold stocks rise, uranium falls Forrestania jumps on iron ore play The ASX 200 edged down -0.2% on Tuesday as local traders navigated a directionless marke... |
Stockhead | HCT | 5 months ago |
Top 10 at 10: Banana recycler slides into big contract win
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers... |
Stockhead | HCT | 5 months ago |
Confused? Here’s what trading halt, pause, and suspension from quotation mean on the ASX
What you should know about the different types of trading halts Why trading halts can protect investors Which companies are currently under suspension For the most part, trading on the ASX takes place without interruption throughout the... |
Stockhead | HCT | 7 months ago |
Biotech Holista Colltech slapped with $1.8m fine for misleading investors
Listed biotech Holista Colltech (ASX: HCT) has been slapped with a $1.8 million penalty for breaching its continuous disclosure obligations and making misleading claims regarding the sales of its broad-spectrum sanitiser product NatShield d... |
businessnewsaustralia.com | HCT | 8 months ago |
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks China’s President Xi is expected... |
Stockhead | HCT | 1 year ago |
Closing Bell: A little victory for local markets as ASX gains and China has a weekend to get serious about winning
Benchmark ASX index ends +0.21%, but down -2.2% this week Consumer stocks offset Tech losses Small caps led by Webcentral The benchmark has ended another tortuous week of trade with a little Friday victory. Down -2.2% for the week, all... |
Stockhead | HCT | 1 year ago |
Closing Bell: ASX ends flat, but it’s not a good flat. More an Oxford Dictionary ‘to lack vigour; dull and lifeless’ flat
Benchmark ASX index closes short by -0.04% Materials sector tries but cannot offset everyone else Small caps led by HAL, DTC The ASX200 Index has closed slightly lower after jumping early (+0.3%) out the gates on Wednesday morning. The... |
Stockhead | HCT | 1 year ago |
In Case You Missed It: A software player takeover and astronaut food launch in Malaysia
Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today. ICYMI Leader... |
Stockhead | HCT | 1 year ago |
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks Goldman Sachs analysts said they will make no... |
Stockhead | HCT | 1 year ago |
Closing Bell: War footing suits ASX as Fed frees a dove
Benchmark ASX index finishes +1% higher ASX Sectors led by Utilities (+4.2%) and all ended higher on the day Funny bunch of small cap winners including MOB, CZR, NGL The ASX200 doesn’t seem to mind a bit of war on Tuesday, rising very... |
Stockhead | HCT | 1 year ago |
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks Be... |
Stockhead | HCT | 1 year ago |
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Morgans says companies on the ASX are propelling our appetite product for health and wellness products Bioxyne says Covid has shown our susceptibility to disease, but also how resilient and strong we are in fighting it Anagenics says it’s... |
Stockhead | HCT | 1 year ago |
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks On... |
Stockhead | HCT | 1 year ago |
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August August was all about earnings, and des... |
Stockhead | HCT | 1 year ago |
Check Up: Australian biotech sector continues to be a magnet for US investors
Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the best and worst performing ASX biotechs over the past month The Australian biotech sector co... |
Stockhead | HCT | 1 year ago |
Obesity drug Wegovy takes the world by storm. Could that impact ASX stocks like Holista Colltech?
The weight loss drug frenzy is taking the world by storm Ozempic and Wegovy take drugmaker Novo Nordis to new highs Stockhead reached out to Holista’s CEO, Dato Dr. Rajendran Marnickacvasagar The recent frenzy over Ozempic and Wegovy h... |
Stockhead | HCT | 1 year ago |
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month Steve Jobs used to say that the most... |
Stockhead | HCT | 1 year ago |
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July The Covid-19 pandemic had produced windfalls for and attracted fa... |
Stockhead | HCT | 1 year ago |
Closing Bell: ASX 200 trades flat on tepid start to week, but Mantle Minerals shines
ASX chopped about sideways, losing any slight semblance of fizz at close: -0.063% IT, Discretionary and Industrials led sectors, while Materials lagged The day’s clear winner was Mantle Minerals, up 50% at day’s end on further exploration... |
Stockhead | HCT | 1 year ago |
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month The world is anticipating a “game changer” as Brisba... |
Stockhead | HCT | 1 year ago |
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week When we talk about dividend-paying hea... |
Stockhead | HCT | 1 year ago |
Closing Bell: Its another win for the ASX on Friday as Austral nabs US$3 billion US Navy deal
S&P/ASX 200 closes up 0.6%, while the emerging companies index rises 0.86% Austral’s US subsidiary Austral USA awarded a contract worth up to US$3.195 billion from the US Navy Pushpay ceases trading on the ASX and NZX following its $1.... |
Stockhead | HCT | 1 year ago |
Closing Bell: Its a win for the ASX, loss for the newly unemployed as Aussie jobless rate rises
S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec... |
Stockhead | HCT | 1 year ago |
CLOSING BELL: Mega gold merger outweighs bankers’ ex-div dive, leaving the ASX up 0.1%
After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike As far as days on the ASX go, that definitely... |
Stockhead | HCT | 1 year ago |
CLOSING BELL: Solid effort from the techies leads a post-lunch recovery to -0.08%
An afternoon rally has put some lead back in the market’s pencil, closing down 0.08%. Tech stocks and Small Ordinaries drive the wins, with InfoTech up 1.5% for the day. Lithium’s back on the menu, with three big names making some chunky,... |
Stockhead | HCT | 1 year ago |
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales
Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s... |
Stockhead | HCT | 1 year ago |
CLOSING BELL: Nobody’s quite game to pick the bottom after the ASX makes it 5 losses on the trot
ASX waddled to a -0.3% close, like a toddler with a turd in its trousers. Even the goldies retreated, with the XGD ASX All Ords Gold index dropping 0.20%. Blackmores sale is the most exciting thing to happen all day… which says it all, rea... |
Stockhead | HCT | 1 year ago |
Closing Bell: ASX sneaks into the green with Mining stocks leading the way
The ASX 200 was up 0.23% while the ASX XEC managed a 0.092% gain 8 out of 11 sectors were higher with Materials leading the way The Real Estate sector was the weakest, down 0.77% The ASX 200 was up 0.23% today while the ASX XEC squeez... |
Stockhead | HCT | 1 year ago |
CLOSING BELL: Be honest. If the Energy sector was a horse right now, you’d shoot it
ASX 200 sinks to -2.2% before recovering to close near -1.5% for the day Energy sector tanks -5.0% because it wants to watch you cry in the shower Low unemployment data sets up the RBA to keep twisting Australia’s nipples, just the way we... |
Stockhead | HCT | 1 year ago |
CLOSING BELL: Who knew you could still make money from inside a burning dumpster?
ASX hammered as bank-driven fear grips the market like a python round a possum XEC Emerging Companies falls more than 2.0% because they’re young and don’t know any better Safe haven goldies still managed to make bank. Sorry… poor choice of... |
Stockhead | HCT | 1 year ago |
CLOSING BELL: And the Oscar for Best Performing Company in a Comedy Drama goes to…
ASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index down 0.84% because it was out partying all weekend. The Goldies take the gongs, after the precious metal jumped more than 1.0% Looking a... |
Stockhead | HCT | 1 year ago |